HUYA Bioscience International and CAS Innovation and Investment Company Establish Strategic Collaboration
HUYA Bioscience International and CAS Innovation and Investment Company Establish Strategic Collaboration
San Diego, CA, USA – January 18, 2017 –HUYA Bioscience International (HUYA), the leader in accelerating the global development of China’s pharmaceutical innovations, announced today a strategic collaboration agreement with the Chinese Academy of Sciences Innovation and Investment Company (referred to as CAS Innovation). The collaboration will focus on developing and commercializing biomedical innovations discovered by leading scientists at CAS to meet the medical needs of patients around the world.